Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2018

Open Access 01-12-2018 | Research

Effect of carglumic acid with or without ammonia scavengers on hyperammonaemia in acute decompensation episodes of organic acidurias

Authors: Anupam Chakrapani, Vassili Valayannopoulos, Nuria García Segarra, Mireia Del Toro, Maria Alice Donati, Angeles García-Cazorla, María Julieta González, Celine Plisson, Vincenzo Giordano

Published in: Orphanet Journal of Rare Diseases | Issue 1/2018

Login to get access

Abstract

Background

Hyperammonaemia is a key sign of decompensation in organic acidurias (OAs) and can contribute to severe neurological complications, thus requiring rapid treatment.

Methods

A post-hoc analysis of two retrospective studies analysed the efficacy of carglumic acid ± ammonia (NH3) scavengers compared with scavengers alone for reducing plasma NH3 levels in patients with OAs and hyperammonaemia (plasma NH3 > 60 μmol/L) during decompensation episodes. NH3 was analysed in 12-h periods at 0–48 h and 24-h periods at 48–120 h. Treatment-emergent adverse events (TEAEs) were recorded.

Results

Of 98 episodes, 38 were treated with carglumic acid (34 patients), 33 with NH3 scavengers (22 patients) and 27 with carglumic acid combined with NH3 scavengers (27 patients). Overall, 45% (carglumic acid group), 46% (NH3 scavengers group) and 74% (combination group) of episodes occurred in neonates. Median episode duration was 6 days for the carglumic acid and combination groups, and 9 days for the NH3 scavenger group. Median baseline NH3 level was: 199 μmol/L, carglumic acid; 122 μmol/L, NH3 scavengers; and 271 μmol/L, combination; 13, 30 and 11% of episodes required extracorporeal detoxification (ED), respectively. Data were censored at ED initiation. While baseline NH3 levels were higher in the combination and carglumic acid groups, mean reduction in NH3 levels to 72 h in both groups was greater than the NH3 scavengers’ group; reductions were greatest in the combination group.
Mean change in plasma NH3 vs baseline in the carglumic acid, NH3 scavengers and combination groups, respectively, was − 13, + 12% and − 27% at 0–12 h (p < 0.05 NH3 scavengers vs combination); − 47, − 22% and − 52% at 12–24 h (not significant); − 44, − 5% and − 61% at 24–48 h; and − 66, − 16% and − 76% at 48–72 h (p < 0.05 carglumic acid/combination groups vs NH3 scavengers for both timepoints). The number of TEAEs was similar between groups and mainly related to the disease/condition.

Conclusions

Carglumic acid is a well-tolerated and efficacious treatment for OA decompensation episodes. When given alone or combined with NH3 scavengers, the reduction in NH3 was greater than with NH3 scavengers alone in the first 72 h.
Literature
1.
go back to reference Dionisi-Vici C, et al. 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis. 2006;29(2–3):383–9.CrossRefPubMed Dionisi-Vici C, et al. 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis. 2006;29(2–3):383–9.CrossRefPubMed
2.
go back to reference Valayannopoulos V, et al. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study. Orphanet J Rare Dis. 2016;11:32.CrossRefPubMedPubMedCentral Valayannopoulos V, et al. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study. Orphanet J Rare Dis. 2016;11:32.CrossRefPubMedPubMedCentral
3.
go back to reference Dercksen M, et al. Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme a esters and the production of alternative glutamate esters. Biochim Biophys Acta. 2014;1842(12 Pt A):2510–6.CrossRefPubMed Dercksen M, et al. Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme a esters and the production of alternative glutamate esters. Biochim Biophys Acta. 2014;1842(12 Pt A):2510–6.CrossRefPubMed
4.
go back to reference Filipowicz HR, et al. Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol Genet Metab. 2006;88(2):123–30.CrossRefPubMed Filipowicz HR, et al. Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol Genet Metab. 2006;88(2):123–30.CrossRefPubMed
6.
7.
go back to reference Filippi L, et al. N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatology. 2010;97(3):286–90.CrossRefPubMed Filippi L, et al. N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatology. 2010;97(3):286–90.CrossRefPubMed
8.
go back to reference Bachmann C. Long-term outcome of patients with urea cycle disorders and the question of neonatal screening. Eur J Pediatr. 2003;162(Suppl 1):S29–33.CrossRefPubMed Bachmann C. Long-term outcome of patients with urea cycle disorders and the question of neonatal screening. Eur J Pediatr. 2003;162(Suppl 1):S29–33.CrossRefPubMed
9.
go back to reference Walker V. Ammonia toxicity and its prevention in inherited defects of the urea cycle. Diabetes Obes Metab. 2009;11(9):823–35.CrossRefPubMed Walker V. Ammonia toxicity and its prevention in inherited defects of the urea cycle. Diabetes Obes Metab. 2009;11(9):823–35.CrossRefPubMed
10.
go back to reference Daniotti M, et al. New developments in the treatment of hyperammonemia: emerging use of carglumic acid. Int J Gen Med. 2011;4:21–8.PubMedPubMedCentral Daniotti M, et al. New developments in the treatment of hyperammonemia: emerging use of carglumic acid. Int J Gen Med. 2011;4:21–8.PubMedPubMedCentral
11.
go back to reference Ah Mew N, et al. N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia. Pediatrics. 2010;126(1):e208–14.CrossRefPubMed Ah Mew N, et al. N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia. Pediatrics. 2010;126(1):e208–14.CrossRefPubMed
12.
go back to reference Europe, O., Carbaglu summary of product characteristics. 2017. Europe, O., Carbaglu summary of product characteristics. 2017.
13.
go back to reference Haberle J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. Arch Biochem Biophys. 2013;536(2):101–8.CrossRefPubMed Haberle J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. Arch Biochem Biophys. 2013;536(2):101–8.CrossRefPubMed
14.
go back to reference Cyr D, Maswoswe S, Tremblay G. Inhibition of the urea cycle and de novo pyrimidine biosynthesis by sodium benzoate. J Inherit Metab Dis. 1987;10(Suppl 2):308–10.CrossRef Cyr D, Maswoswe S, Tremblay G. Inhibition of the urea cycle and de novo pyrimidine biosynthesis by sodium benzoate. J Inherit Metab Dis. 1987;10(Suppl 2):308–10.CrossRef
15.
go back to reference Zschocke J, Hoffman G. Diagnosis and management of metabolic disorders, in Vademecum metabolicum diagnosis and treatment of inborn errors of metabolism. Germany: Schattauer Gmbh; 2011. Zschocke J, Hoffman G. Diagnosis and management of metabolic disorders, in Vademecum metabolicum diagnosis and treatment of inborn errors of metabolism. Germany: Schattauer Gmbh; 2011.
17.
go back to reference Summar M. Current strategies for the management of neonatal urea cycle disorders. J Pediatr. 2001;138(1 Suppl):S30–9.CrossRefPubMed Summar M. Current strategies for the management of neonatal urea cycle disorders. J Pediatr. 2001;138(1 Suppl):S30–9.CrossRefPubMed
18.
go back to reference Orphan Europe. Carbaglu summary of product characteristics. 2016. Orphan Europe. Carbaglu summary of product characteristics. 2016.
Metadata
Title
Effect of carglumic acid with or without ammonia scavengers on hyperammonaemia in acute decompensation episodes of organic acidurias
Authors
Anupam Chakrapani
Vassili Valayannopoulos
Nuria García Segarra
Mireia Del Toro
Maria Alice Donati
Angeles García-Cazorla
María Julieta González
Celine Plisson
Vincenzo Giordano
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2018
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-018-0840-4

Other articles of this Issue 1/2018

Orphanet Journal of Rare Diseases 1/2018 Go to the issue